The Pharmacology Center

Filter Your Results

 

News

 

French Study Evaluates TAVR-Related Microbleeds

March 19, 2017 -- The American College of Cardiology (ACC) announced the results of a single-center study of 84 patients (age ≥ 80 years) undergoing transcatheter aort…

CT Scans Show Reduced Leaflet Motion After TAVR in RESOLVE and SAVORY Registries

March 19, 2017 -- The American College of Cardiology (ACC) announced that an observational study found that approximately 12% of patients undergoing aortic valve replacement d…

RE-CIRCUIT Evaluates Dabigatran in Patients Undergoing Catheter Ablation of Atrial Fibrillation

March 19, 2017 -- The American College of Cardiology (ACC) announced that a study demonstrated the uninterrupted treatment with dabigatran, a non -- vitamin K antagonist oral …

Closing Left Atrial Appendage Shown to Reduce Stroke Risk From Atrial Fibrillation

March 19, 2017 -- For patients with atrial fibrillation (AF), closing the left atrial appendage as an add-on procedure during cardiac surgery was associated with a 40% reducti…

EINSTEIN CHOICE Studies Low-Dose Rivaroxaban to Reduce VTE Recurrence

March 18, 2017 -- The American College of Cardiology (ACC) announced that findings from the EINSTEIN CHOICE study demonstrated that a low dose of the oral anticoagulant rivaro…

GEMINI-ACS-1 Study Evaluates Safety of Rivaroxaban in Post-ACS Patients

March 18, 2017 -- The American College of Cardiology (ACC) announced that findings from the GEMINI-ACS-1 study demonstrated that patients with acute coronary syndrome (AC…

DECISION CTO Compares PCI With Optimal Medical Therapy

March 18, 2017 -- The American College of Cardiology announced the presentation of data from the DECISION CTO randomized trial by lead investigator Seung-Jung Park, MD, at the…

Daiichi Sankyo Begins Study of Edoxaban in AF Patients Undergoing PCI With Stenting

March 10, 2017 -- Daiichi Sankyo Company, Inc. announced that the first patient has been enrolled into the ENTRUST-AF PCI study, which will compare a treatment regimen based o…

 

advertisement

2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007, with its launch issue focusing on the state of coronary drug-eluting stent use. Each edition will cover a variety of topics in a flexible format that includes articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's cardiology practices.